ProfileGDS4718 / 225326_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 88% 85% 91% 85% 88% 89% 92% 87% 88% 87% 88% 89% 90% 86% 90% 89% 88% 85% 90% 74% 83% 86% 87% 89% 88% 89% 90% 89% 86% 90% 91% 90% 87% 88% 94% 91% 88% 88% 88% 91% 88% 88% 87% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.9731688
GSM549102patient 115, normal, homogenized [OPG study]8.4288585
GSM549104patient 119, normal, homogenized [OPG study]9.4673491
GSM549108patient 138, normal, homogenized [OPG study]8.4062985
GSM549119patient 077, normal, homogenized [OPG study]8.935388
GSM549133patient 032, cancer, homogenized [OPG study]9.1053389
GSM549139patient 042, cancer, homogenized [OPG study]9.4402792
GSM549099patient 107, normal, homogenized [OPG study]8.68287
GSM549109patient 139, normal, homogenized [OPG study]8.8929588
GSM549110patient 046, normal, homogenized [OPG study]8.8227487
GSM549114patient 063, normal, homogenized [OPG study]9.0553488
GSM549122patient 082, normal, homogenized [OPG study]8.9803889
GSM549134patient 033, cancer, homogenized [OPG study]9.1507890
GSM549136patient 036, cancer, homogenized [OPG study]8.6608386
GSM549140patient 044, cancer, homogenized [OPG study]9.2467990
GSM549111patient 047, normal, homogenized [OPG study]9.064989
GSM549113patient 057, normal, homogenized [OPG study]9.0884288
GSM549132patient 031, cancer, homogenized [OPG study]8.4642785
GSM549137patient 038, cancer, homogenized [OPG study]9.2114490
GSM549142patient 047, cancer, homogenized [OPG study]7.132974
GSM549100patient 110, normal, homogenized [OPG study]8.0897983
GSM549107patient 135, normal, homogenized [OPG study]8.6540986
GSM549115patient 068, normal, homogenized [OPG study]8.8517287
GSM549116patient 072, normal, homogenized [OPG study]9.0682289
GSM549120patient 078, normal, homogenized [OPG study]8.8852688
GSM549131patient 030, cancer, homogenized [OPG study]9.0414889
GSM549118patient 074, normal, homogenized [OPG study]9.2461990
GSM549129patient 027, cancer, homogenized [OPG study]8.9897489
GSM549123patient 088, normal, homogenized [OPG study]8.6849486
GSM549124patient 006, cancer, homogenized [OPG study]9.113990
GSM549126patient 015, cancer, homogenized [OPG study]9.2942791
GSM549128patient 025, cancer, homogenized [OPG study]9.1605290
GSM549103patient 117, normal, homogenized [OPG study]8.5469987
GSM549117patient 073, normal, homogenized [OPG study]9.0879388
GSM549138patient 041, cancer, homogenized [OPG study]9.8473994
GSM549141patient 045, cancer, homogenized [OPG study]9.4179991
GSM549130patient 028, cancer, homogenized [OPG study]8.8332988
GSM549101patient 111, normal, homogenized [OPG study]8.820988
GSM549105patient 128, normal, homogenized [OPG study]8.776688
GSM549106patient 134, normal, homogenized [OPG study]9.5097391
GSM549112patient 048, normal, homogenized [OPG study]8.945988
GSM549125patient 011, cancer, homogenized [OPG study]8.838788
GSM549127patient 024, cancer, homogenized [OPG study]8.6952887
GSM549135patient 035, cancer, homogenized [OPG study]9.4015991